“Vivir no es sólo existir, sino existir y crear, saber gozar y sufrir y no dormir sin soñar. Descansar, es empezar a morir” Gregorio Marañón

A Stanford Medicine study found that an “immune system reset” can potentially reverse autoimmune, or Type 1, diabetes. The strategy may also be applicable to other autoimmune diseases and organ transplantation. https://t.co/Vb2ZhkVEaK

Influenza remains an important cause of illness and death. In a phase 3 trial, a nucleoside-modified mRNA (modRNA) quadrivalent vaccine was found to be superior to a standard quadrivalent vaccine in preventing influenza illness. Full trial results: https://t.co/C9fQZkdWSz

New content online: Insights into the pathogenesis of childhood-onset SLE in the past decade https://t.co/6pAJz4i91S

El futuro es incierto, pero también apasionante, qué veremos en los próximos 10 años, cómo deberá evolucionar nuestra profesión… lo que es cierto es que habrá que integrar el desarrollo tecnológico en nuestro trabajo y redefinir nuestras habilidades como médicos

El #Hospital La Paz aplica una terapia pionera de CAR-T en Europa a jóvenes con #leucemia ⬇️ https://t.co/7v2gXs0Z3x

Beautiful diagram depicting all aspects of ANCA-Associated Vasculitis (AAV) 🩸 It perfectly shows how: 🔹 PR3-ANCA → GPA — airway & ENT disease, granulomas, relapsing course 🔹 MPO-ANCA → MPA — pulmonary–renal, ILD, neuropathy, higher mortality 🔹 EGPA — eosinophilia,

Macrophage Activation Syndrome/HLH 💊Treatment targets & Pathogenesis of HLH vs MAS 🚩 IL-18 ➡️ IFN-γ axis drives inflammation; high IL-18 subset leads to a high MAS risk #Rheumatology #MedTwitter #ACR2025

ANCA-associated vasculitis and interstitial lung disease: challenges a...

New content online: Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis https://t.co/2hS0GnMCjc

📢 La Dra. Lucía Platero Dueñas presentó una sesión clave sobre las novedades terapéuticas en nefropatía IgA: avances en tratamientos, nueva evidencia clínica y esperanzas renovadas para pacientes y profesionales. ✅💡 🔗 https://t.co/TSqKUAxbif #NefropatíaIgA @JJRiosBlanco

Will A.I. lead to de-skilling of physicians? And if so what can be done to preempt it? @tberzin and I address this in a new @TheLancet piece https://t.co/rK5Lf77YtK

"It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has." – William Osler

Checkpoint inhibitors are the mainstay of cancer immunotherapy. Here's a new review article for the current state of the science and where we're headed @SciImmunology https://t.co/YNDp5YvKuc

Es el mejor, y nos dedica su premio a los que hacemos guardias Viva Noah y the Pitt 🏥

Clinical characteristics and outcomes of elderly patients with ANCA-associated vasculitis

Hyperferritinemia is common in Hyperinflammatory syndromes but is a hallmark of Macrophage activation syndrome and Sepsis; and is a poor prognostic sign too. MAS is excessive activation of T-lymphocytes & macrophages leading to cytokine storm & multi-organ damage.

ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease ⏩Early screening: HRCT recommended in SSc, MCTD & high-risk IIM; RA & Sjögren with risk factors. ⏩Close monitoring: ⏩Tailored treatment https://t.co/imHNb3X330

Anti-MDA5 DM is assoc w/ rapidly progr ILD & mortality risk. 26 MD5+ DM pts (age 56.6 yrs; 7/26 male) Sxs: Gottrón’s (81%), ILD (73%), periungual erythema (69%), heliotrope (61%), V-sign (42%), arthritis (42%), weakness (38%), mechanic’s (35%), Raynaud’s (19%). 7/19 RP-ILD died

Discovery of a new type of immune cell in fat tissue that promotes infllammaging (chronic inflammation with aging) https://t.co/6vGvP0WBTS https://t.co/dKefHSM4Nq

🚀 INICIO DEL III EXPERTO EN EL USO AVANZADO DE LA INTELIGENCIA ARTIFICIAL EN INVESTIGACIÓN Y DOCENCIA EN CIENCIAS DE LA SALUD 🗓️ 15 de OCTUBRE!!! Empieza el III Experto del Programa Universitario de Postgrado “Máster en el Uso de la Inteligencia Artificial en Investigación y